Correlation Between Liquidia Technologies and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Liquidia Technologies and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Liquidia Technologies and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Liquidia Technologies and Biomarin Pharmaceutical, you can compare the effects of market volatilities on Liquidia Technologies and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Liquidia Technologies with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Liquidia Technologies and Biomarin Pharmaceutical.
Diversification Opportunities for Liquidia Technologies and Biomarin Pharmaceutical
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Liquidia and Biomarin is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Liquidia Technologies and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and Liquidia Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Liquidia Technologies are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of Liquidia Technologies i.e., Liquidia Technologies and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between Liquidia Technologies and Biomarin Pharmaceutical
Given the investment horizon of 90 days Liquidia Technologies is expected to generate 1.78 times more return on investment than Biomarin Pharmaceutical. However, Liquidia Technologies is 1.78 times more volatile than Biomarin Pharmaceutical. It trades about 0.43 of its potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.17 per unit of risk. If you would invest 1,246 in Liquidia Technologies on November 9, 2024 and sell it today you would earn a total of 350.00 from holding Liquidia Technologies or generate 28.09% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Liquidia Technologies vs. Biomarin Pharmaceutical
Performance |
| Timeline |
| Liquidia Technologies |
| Biomarin Pharmaceutical |
Liquidia Technologies and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Liquidia Technologies and Biomarin Pharmaceutical
The main advantage of trading using opposite Liquidia Technologies and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Liquidia Technologies position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.| Liquidia Technologies vs. Biomarin Pharmaceutical | Liquidia Technologies vs. Vaxcyte | Liquidia Technologies vs. Legend Biotech Corp | Liquidia Technologies vs. Bio Techne Corp |
| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |